LONG-TERM EFFECTS OF TNF-ALPHA INHIBITORS ON BONE MINERAL DENSITY AND THE INCIDENCE OF VERTEBRAL FRACTURES IN PATIENTS WITH ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Beek, K. [1 ,2 ]
van der Weijden, M. [1 ,2 ]
Lems, W. [1 ,2 ]
van Denderen, C. [3 ]
Nurmohamed, M. [1 ,2 ]
van der Horst-Bruinsma, I. [1 ,2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam Rheumatol Immunol Ctr, Rheumatol, Amsterdam, Netherlands
[2] Reade, Amsterdam, Netherlands
[3] Reade, Amsterdam Rheumatol Immunol Ctr, Rheumatol, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0374
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [21] Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: A cross-sectional study
    Jun, Jae-Bum
    Joo, Kyung-Bin
    Her, Min-Young
    Kim, Tae-Hwan
    Bae, Sang-Cheol
    Yoo, Dae-Hyun
    Kim, Seong-Kyu
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (08) : 1637 - 1641
  • [22] Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures.
    van der Weijden, M. A. C.
    van Denderen, J. C.
    Lems, W. F.
    Nurmohamed, M. T.
    Dijkmans, B. A. C.
    van der Horst-Bruinsma, I. E.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1118 - S1118
  • [23] Long term use of TNF inhibitors for Ankylosing Spondylitis
    Wazir, T. U.
    O'Brien, L.
    Bell, A. L.
    Cairns, A. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S545 - S545
  • [24] Bone mineral density in patients with ankylosing spondylitis
    Altindag, Oezlem
    Karakoc, Mehmet
    Soran, Neslihan
    Tabur, Hasan
    Demirkol, Ahmet
    ROMATIZMA-RHEUMATISM, 2008, 23 (02): : 42 - 45
  • [25] The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
    Axel Svedbom
    Johan Dalén
    Moa Ivergård
    Rebekah H. Borse
    Christopher M. Black
    Karin Luttropp
    Sumesh Kachroo
    The European Journal of Health Economics, 2020, 21 : 45 - 54
  • [26] The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
    Svedbom, Axel
    Dalen, Johan
    Ivergard, Moa
    Borse, Rebekah H.
    Black, Christopher M.
    Luttropp, Karin
    Kachroo, Sumesh
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (01): : 45 - 54
  • [27] THE VALUE OF PERSISTENCE IN TREATMENT WITH SUBCUTANEOUS TNF-ALPHA INHIBITORS FOR ANKYLOSING SPONDYLITIS
    Ivergard, M.
    Dalen, J.
    Svedbom, A.
    Black, C. M.
    Borse, R. H.
    Kachroo, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 840 - 841
  • [28] NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND BONE MINERAL DENSITY AND FRACTURES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Sanchez, M. D.
    Montilla-Morales, C. A.
    Gomez-Castro, S.
    Hidalgo-Calleja, C.
    Carranco-Medina, T.
    Calero-Paniagua, I.
    Quesada-Moreno, A.
    del Pino-Montes, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1037 - 1037
  • [29] Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis
    Feldtkeller, E
    Vosse, D
    Geusens, P
    van der Linden, S
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (03) : 234 - 239
  • [30] Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis
    Kang, Kwi Young
    Kim, In Je
    Jung, Seung Min
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Park, Kyung-Su
    Hong, Yeon Sik
    Park, Sung-Hwan
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (03)
12345